A Record Based Analysis of Outcome of Organophosphorus Compound Poisonings in Tertiary Care Hospital Mandya

doi:10.5281/zenodo.7838651

International Journal of Medical and Pharmaceutical Research

2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7838651

Original Article

A Record Based Analysis of Outcome of Organophosphorus Compound Poisonings in Tertiary Care Hospital Mandya

Dr. Ramakrishna S

Dr. Arundhati R Chitnis

Dr. Chethan Kumar K L

Dr. Vaishak. K .M

DOI : 10.5281/zenodo.7838651

Published

April 18, 2023

Abstract

Background: This study aimed to investigate factors that may impact survival in patients exposed to organophosphorus compound, including route of exposure, presence of certain symptoms , duration of ICU stay and mechanical ventilation. Understanding these factors can help inform treatment decisions and improve patient outcomes. Methods: A retrospective study was conducted on patients who presented to our hospital between 2021 and 2022 with exposure to organophosphorus compound. Data on demographics, route of exposure, and symptoms were collected and analyzed. Survival rates were calculated and compared across different subgroups. Results: Of the 120 patients included in the study, the overall mortality rate was 9%. Males had a higher survival rate than females (92% vs. 85%). Patients who inhaled the compound had a higher survival rate (100%) than those who ingested it (96%). Patients with diarrhea had a 100% survival rate, while those with bronchial secretion had an 18% survival rate. Fasciculations were not found to be a significant predictor of mortality. Conclusion: Our study provides insight into the factors that may impact survival in patients exposed to organophosphorus compound. More research is needed to fully understand the complex interplay of factors that contribute to mortality in these cases.

Recommended Articles

Volume-4, Issue-2

Downloads

Download PDF pdf

Download XML

Citations

1103 Views

4 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.